This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: I46 (cardiac arrest) | Special Copayment Reduction: V192 (Special Copayment Reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Sudden cardiac arrest (SCA), ventricular fibrillation, pulseless VT, cardiopulmonary arrest, sudden cardiac death (SCD) |
| C. Adult onset | Occurs predominantly in adult men in their 50s–70s, with underlying coronary artery disease, heart failure and cardiomyopathy as the main background conditions. About 70–80% of all out-of-hospital cardiac arrests occur in adults. |
| 1. History | Modern cardiopulmonary resuscitation (CPR) established in the 1960s. Kouwenhoven's introduction of chest compressions (1960) and the invention of the defibrillator revolutionized resuscitation from cardiac arrest. |
| 2. Causes | Coronary artery disease (most common), non-ischemic cardiomyopathy, cardiac ion channel abnormalities, electrolyte disturbances; non-cardiac causes such as pulmonary embolism and tension pneumothorax are also included. |
| 3. Genetics | Genes associated with inherited arrhythmia syndromes, such as SCN5A, KCNQ1, KCNH2 and CACNA1C, are associated with susceptibility to sudden cardiac death. |
| 4. General epidemiology | The incidence of out-of-hospital cardiac arrest is about 55–100 per 100,000 per year in the United States, with more than about 30,000 cases annually in Korea. The survival-to-discharge rate is around 5–15%. |
| 5. Pathophysiology | Ventricular fibrillation and pulseless ventricular tachycardia are the most common initial rhythms. Myocardial electrical instability and formation of reentrant circuits are the core pathophysiology. |
| 6. Symptoms | Sudden loss of consciousness, apnea or agonal breathing, and loss of pulse appear immediately. Prodromal symptoms (chest pain, dizziness) are observed in about 50%. |
| 7. Signs | Unresponsiveness, apnea or agonal breathing, and absent carotid pulse are the diagnostic signs. Cyanosis of the skin and pupillary dilation appear within minutes. |
| 8. Screening | LVEF measurement, Holter monitoring, EPS, cardiac MRI and genetic testing are used for risk assessment before ICD implantation. |
| 9. Diagnosis | Along with clinical diagnosis (loss of consciousness + pulselessness), the cause is identified with ECG, cardiac enzymes, echocardiography, coronary angiography and blood tests (electrolytes, toxicology). |
| 10. Treatment | Immediate CPR and early defibrillation are key. Post-resuscitation targeted temperature management (TTM), coronary angiography, correction of the cause and ICD implantation are follow-up treatments. |
| 11. Prognosis | Survival with good neurological outcome for all out-of-hospital cardiac arrests is about 8–10%. Under conditions of witnessed arrest + immediate CPR + early defibrillation, survival rises to 40–60%. |
| 12. Prevention | ICD implantation (primary/secondary prevention), treatment of underlying heart disease, expanded CPR training for the public, and deployment of automated external defibrillators (AED) in public places are the key prevention strategies. |
| 13. References | Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: 2024 Update of the Utstein Out-of-Hospital Cardiac Arrest Registry Template … and 9 other papers |
The history of cardiac arrest and its resuscitation is counted among the most dramatic advances in the history of medicine. Until the 18th century cardiac arrest meant death, but in the 19th century basic resuscitation concepts began to be systematized. In 1799 Alexander von Humboldt described resuscitation attempts using electrical stimulation, and in the 1850s Moritz Schiff successfully performed open-chest cardiac massage on dogs.
Modern cardiopulmonary resuscitation (CPR) originated in the late 1950s to early 1960s. In 1958 Peter Safar established mouth-to-mouth ventilation, and in 1960 Kouwenhoven, Jude and Knickerbocker published the closed-chest cardiac massage technique, proving that systemic circulation could be maintained by chest compression alone. This publication is regarded as the birth of modern CPR, which then spread rapidly worldwide. In the same period, in 1960, Bernard Lown developed the direct-current defibrillator (DC defibrillator), making it possible to restore normal rhythm with an electric shock in cardiac arrest due to ventricular fibrillation.
In the 1970s the automated external defibrillator (AED) was developed, and in the 1980s the implantable cardioverter-defibrillator (ICD) was introduced into clinical practice by Michel Mirowski. Subsequently, miniaturization and cost reduction of AEDs enabled their deployment in public places, and early defibrillation by laypersons was shown to greatly improve survival.
In the 2000s, randomized controlled trials proved that post-resuscitation therapeutic hypothermia (later renamed targeted temperature management, TTM) improves neurological outcomes, and it became the standard of post-resuscitation care. Since 2010, the importance of high-quality CPR along with integrated post-cardiac arrest care has been emphasized. In the 2025 AHA guidelines, reorganization of resuscitation training systems, standardization of data registries (Utstein criteria), and strengthening of community response systems were addressed as key agenda items.
The causes of cardiac arrest are broadly classified as cardiac and non-cardiac. Cardiac causes account for about 70–80% of the total, and the most common of these is coronary artery disease. Myocardial ischemia due to acute myocardial infarction or unstable angina is the direct trigger of ventricular fibrillation. Myocardial scar due to chronic ischemic heart disease also forms the substrate for reentrant ventricular tachycardia.
Non-ischemic cardiomyopathy includes dilated, hypertrophic and ARVC (arrhythmogenic right ventricular cardiomyopathy) types and is an important cause of sudden cardiac death. In ARVC in particular, fibrofatty replacement of the right ventricle predisposes to ventricular fibrillation and ventricular tachycardia. Cardiac ion channel abnormalities include long QT syndrome, Brugada syndrome, catecholaminergic polymorphic VT (CPVT) and short QT syndrome, which can cause sudden cardiac death even without structural heart disease.
Non-cardiac causes include pulmonary embolism (massive), tension pneumothorax, cardiac tamponade, hypovolemic shock, hypoxemia, electrolyte abnormalities (hypokalemia, hyperkalemia, hypomagnesemia) and drug overdose/poisoning (tricyclic antidepressants, digoxin, antiarrhythmics), which are systematically differentiated during resuscitation using the 4H/4T framework. Cardiac arrest due to trauma is classified separately because its causes and prognosis are distinct.
In cardiac arrest, especially unexplained sudden cardiac death without structural heart disease, the contribution of genetic causes is considerable. Postmortem genetic testing (molecular autopsy) is reported to find a causal genetic variant in about 25–35%.
Long QT syndrome (LQTS) arises from variants in multiple ion channel genes such as KCNQ1 (LQT1), KCNH2 (LQT2) and SCN5A (LQT3) and causes torsades de pointes and ventricular fibrillation during exercise or emotional stress. In Brugada syndrome, SCN5A loss-of-function variants are the most common cause, and ventricular fibrillation is triggered by fever or by taking sodium channel–blocking drugs. CPVT is mainly caused by RYR2 (ryanodine receptor 2) variants, and polymorphic ventricular tachycardia occurs with exercise or catecholamine stimulation.
About 60% of hypertrophic cardiomyopathy (HCM) is due to variants in sarcomere protein genes such as MYBPC3 and MYH7, and ventricular hypertrophy and fibrosis confer a high risk of sudden cardiac death. ARVC is mainly caused by variants in desmosomal protein genes, including PKP2 (plakophilin-2). In first-degree relatives of cardiac arrest survivors or young victims of sudden cardiac death, systematic family screening based on gene panel testing, ECG and cardiac MRI is recommended.
Out-of-hospital cardiac arrest (OHCA) is one of the leading causes of death worldwide. About 350,000 OHCAs occur annually in the United States (about 100 per 100,000), and about 275,000 are reported in Europe. In Korea, according to Korea Disease Control and Prevention Agency (KDCA) data, about 30,000–35,000 OHCAs occur annually, corresponding to about 60 per 100,000.
Men have about 2–3 times higher incidence than women, and the median age at onset is 60–70 years. About 70% of all cardiac arrests occur at home, and about 15–20% in public places. The proportion of witnessed arrests varies greatly by country but is roughly 35–55%, and the bystander CPR rate in Korea has been improving, at about 20–30% as of the 2020s.
The initial ECG rhythm is shockable (ventricular fibrillation or pulseless ventricular tachycardia) in about 25–35% of all OHCAs, and the rest are asystole or pulseless electrical activity (PEA). Survival with shockable rhythms is markedly higher than with non-shockable rhythms. The survival-to-discharge rate of in-hospital cardiac arrest (IHCA) is 20–30% depending on country and institution, higher than that of OHCA. About 50–60% of survivors show good neurological recovery.
The core pathophysiology of cardiac arrest is the cessation of effective mechanical contraction of the heart with loss of systemic blood circulation. This occurs with four ECG rhythm patterns: (1) ventricular fibrillation (VF), (2) pulseless ventricular tachycardia (pulseless VT), (3) pulseless electrical activity (PEA), (4) asystole.
Ventricular fibrillation is a state of chaotic electrical excitation of the ventricular muscle in which the ventricles quiver instead of contracting. Heterogeneous shortening of action potential duration due to myocardial ischemia, calcium overload and extracellular hyperkalemia form the electrophysiological basis of ventricular fibrillation. Formation of reentry circuits — a phenomenon in which excitation waves circulate continuously around zones of functional block — is the mechanism that sustains ventricular fibrillation.
In ischemic cardiac arrest, ATP depletion causes the Na/K-ATPase pump to lose function, so intracellular Na⁺ and Ca²⁺ accumulate, and the resulting calcium overload promotes cardiomyocyte death (necrosis and apoptosis). On return of spontaneous circulation (ROSC) after cardiac arrest, reperfusion-reoxygenation injury (reperfusion injury) additionally occurs, and reactive oxygen species (ROS), complement activation and release of inflammatory mediators cause serious damage, especially to the brain and myocardium. This process is called post-cardiac arrest syndrome, in which brain injury, myocardial dysfunction, systemic ischemia-reperfusion response and the persisting underlying cause act together.
The clinical presentation of cardiac arrest is dramatic and immediate. The most characteristic symptom is sudden loss of consciousness; the patient collapses without any warning or within seconds. Simultaneously, loss of normal breathing occurs, and agonal breathing — irregular, labored gasping — may be observed for tens of seconds to several minutes before resuscitation begins. Because bystanders sometimes mistake this for normal breathing and delay CPR, public education about agonal breathing is very important.
Prodromal symptoms may appear minutes to hours before cardiac arrest in about 50% of patients. The most common prodromal symptom is chest pain or chest discomfort (about 30%), and dizziness, dyspnea, presyncope and palpitations may accompany it. In patients with ischemic heart disease in particular, new chest pain or severe dyspnea requires immediate medical response. Seizure-like activity may occur early in cardiac arrest and may be mistaken for an epileptic seizure, delaying resuscitation.
The objective signs of cardiac arrest can be confirmed immediately. The most essential sign is absence of the carotid pulse. However, because CPR may be delayed when pulse checking takes more than 10 seconds, even in cases that are not cardiac arrest, current guidelines recommend that laypersons start CPR immediately based on unresponsiveness and absence of normal breathing rather than a pulse check.
Complete unresponsiveness — no response even to painful stimuli — is confirmed, and within minutes cyanosis appears on the lips and fingertips and toes. The pupils become dilated within the first few minutes and the light reflex is lost, but this is not an absolute indicator of death and must not be used as grounds for stopping resuscitation. Urinary and fecal incontinence may occur. On cardiac auscultation, heart sounds are absent or extremely faint, and blood pressure cannot be measured. On the cardiac monitor, irregular high-amplitude waveforms are seen in ventricular fibrillation and an isoelectric line in asystole.
Because cardiac arrest itself is a clinical diagnosis, no separate screening test is needed, but screening of groups at risk of cardiac arrest is an important preventive task. High-risk groups for cardiac arrest include patients with heart failure (LVEF ≤35%), a history of myocardial infarction, inherited arrhythmia syndromes, ARVC, hypertrophic cardiomyopathy, or a history of unexplained syncope.
Echocardiography for measurement of left ventricular ejection fraction (LVEF) is central to evaluating ICD indications. 24-hour Holter monitoring is used to capture high-risk arrhythmia patterns such as nonsustained ventricular tachycardia. Signal-averaged ECG detects late potentials to assess the substrate for ventricular tachycardia and ventricular fibrillation. If sustained monomorphic ventricular tachycardia is induced on electrophysiological study (EPS), it is an additional indication for ICD implantation.
Cardiac MRI quantifies myocardial fibrosis (late gadolinium enhancement) to assess the substrate for ventricular fibrillation and is important for diagnosing ARVC, HCM and others. When an inherited arrhythmia syndrome is suspected, QT interval measurement, Brugada pattern provocation testing (administration of a sodium channel blocker) and exercise stress testing are performed.
Cardiac arrest is diagnosed clinically: unresponsiveness + no normal breathing + no pulse (or a very uncertain pulse). In an emergency, CPR must be started immediately after confirming these three, and resuscitation must not be delayed to confirm the diagnosis.
During resuscitation, checking the ECG rhythm with a cardiac monitor/defibrillator is essential. When a shockable rhythm (VF/pulseless VT) is identified, immediate defibrillation is performed. After return of spontaneous circulation (ROSC), a 12-lead ECG is obtained to check for ST changes (ST-elevation myocardial infarction, etc.), and blood tests (cardiac troponin, electrolytes, arterial blood gas, blood glucose, toxicology screening) are performed immediately. Emergency echocardiography rapidly assesses myocardial contractile function, pericardial effusion, right ventricular strain due to pulmonary embolism, and so on.
The timing of coronary angiography after ROSC without ST elevation is controversial, but recent large studies suggest that immediate PCI is performed when STEMI is present, and selective early or delayed angiography may be performed in the absence of STEMI. Brain CT and MRI are used to assess the extent of brain injury.
Treatment of cardiac arrest is divided into the pre-arrest prevention phase, the resuscitation phase and the post-resuscitation care phase.
In the resuscitation phase, high-quality chest compressions (for adults: compression depth 5–6cm, rate 100–120/min, complete chest recoil, minimal interruptions) are key. For ventricular fibrillation/pulseless VT, defibrillation should be performed as soon as possible (repeating CPR at 2-minute intervals after the first shock), with shock energy of 120–200J for biphasic waveforms (first shock), then repeated at the same or increased energy. The airway is secured with a supraglottic airway (SGA) or endotracheal intubation, and epinephrine (adrenaline) 1mg IV is repeated every 3–5 minutes. Amiodarone or lidocaine is used after epinephrine in VF/pulseless VT.
The core of post-resuscitation care is targeted temperature management (TTM, 32–36°C, maintained for 24 hours) to minimize neurological injury. Hypotension after ROSC (MAP <65mmHg) is corrected with fluids, vasopressors and, if needed, mechanical circulatory support (IABP, VA-ECMO). Ischemic causes are corrected through coronary angiography and PCI when needed, and after correction of the cause, secondary prevention is achieved through ICD implantation.
The prognosis of out-of-hospital cardiac arrest is poor overall, but survival varies greatly according to system and individual factors. The survival-to-discharge rate for all OHCAs is about 5–15%, and survival with good neurological outcome (CPC 1–2) is about 5–10%. However, when all three conditions — witnessed arrest, immediate CPR and early defibrillation (including AED) — are met, survival can rise to 40–60%.
When the initial rhythm is ventricular fibrillation, survival is about 25–30%, markedly higher than the 5–10% for asystole/PEA. Neurological prognosis after resuscitation depends on resuscitation time, whether targeted temperature management is performed, and the cause of cardiac arrest. After 72 hours from resuscitation, the pupillary light reflex, corneal reflex, brainstem reflexes, EEG, neuron-specific enolase (NSE) levels and brain MRI are combined to predict neurological prognosis. In patients who receive an ICD after survival, the risk of recurrence within 1 year is about 10–20%. Cardiac arrest survivors are at high risk of post-traumatic stress disorder (PTSD), cognitive decline and depression and need psychosocial support.
Prevention of cardiac arrest is divided into primary prevention (preventing occurrence) and secondary prevention (preventing recurrence). The core of primary prevention is early detection and active treatment of underlying cardiovascular disease. In patients with coronary artery disease, drug therapy with aspirin, statins, ACEI/ARB, beta-blockers and the like reduces the risk of cardiac arrest. In heart failure patients with LVEF ≤35% despite optimal drug therapy and a life expectancy of more than 1 year, ICD implantation is recommended for primary prevention.
Expanding CPR training for the public and deploying public AEDs are the most effective community strategies to increase OHCA survival. In Korea, AED installation is mandatory in public buildings and multi-use facilities. Shortening emergency medical services (EMS) response times and establishing a culture of bystander CPR are also important. The spread of smartphone-based CPR support apps (automatic alerts, guidance to nearby AED locations) is contributing to strengthening the chain of survival. Secondary prevention consists of ICD implantation, catheter ablation and correction of the underlying disease in cardiac arrest survivors or patients with high-risk arrhythmias.
Berg KM, Soar J, Andersen LW, et al. Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: 2024 Update of the Utstein Out-of-Hospital Cardiac Arrest Registry Template. Circulation. 2024;150(13):e218-e242. DOI: 10.1161/CIR.0000000000001243. PMID: 39159033.
Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16_suppl_2):S366-S468. DOI: 10.1161/CIR.0000000000000916. PMID: 33081529.
Gräsner JT, Wnent J, Herlitz J, et al. Survival after out-of-hospital cardiac arrest in Europe — Results of the EuReCa TWO study. Resuscitation. 2020;148:218-226. DOI: 10.1016/j.resuscitation.2019.12.042. PMID: 32027980.
Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. Resuscitation. 2021;161:220-269. DOI: 10.1016/j.resuscitation.2021.02.012. PMID: 33773827.
Dumas F, Rea TD, Fahrenbruch C, et al. Chest compression alone cardiopulmonary resuscitation is associated with better long-term survival compared with standard cardiopulmonary resuscitation. Circulation. 2013;127(4):435-441. DOI: 10.1161/CIRCULATIONAHA.112.124115. PMID: 23271797.
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Am Coll Cardiol. 2018;72(14):e91-e220. DOI: 10.1016/j.jacc.2017.10.054. PMID: 29097296.
Tseng ZH, Vittinghoff E, Ursell PC, et al. Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death: POST SCD Study. Circulation. 2018;137(25):2689-2700. DOI: 10.1161/CIRCULATIONAHA.117.033427. PMID: 29440111.
Morozumi T, Kikuchi S, Ohkawa K, et al. Impact of Updating the Cardiopulmonary Resuscitation Guidelines on Out-of-Hospital Shockable Cardiac Arrest: A Population-Based Cohort Study in Japan. J Am Heart Assoc. 2024;13(6):e032518. DOI: 10.1161/JAHA.123.032518. PMID: 38456360.
Callaway CW, Soar J, Aibiki M, et al. Part 4: Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015;132(16 Suppl 1):S84-S145. DOI: 10.1161/CIR.0000000000000273. PMID: 26472860.
Harukuni I, Bhatt DL, Topol EJ. Out of hospital cardiac arrest — new insights and a call for a worldwide registry and guidelines. Eur Heart J. 2024;45(38):3921-3923. DOI: 10.1093/eurheartj/ehae508. PMID: 39095722.